Growth Metrics

Opus Genetics (IRD) Depreciation Expense (2011 - 2014)

Opus Genetics (IRD) reported Depreciation Expense of $3744.0 for Q3 2014, down 61.18% year-over-year from $9645.0 in Q3 2013, and down 61.12% on a QoQ basis from $9630.0 in Q2 2014.

Opus Genetics (IRD) has 4 years of Depreciation Expense data on file, last reported at $3744.0 in Q3 2014.

  • Quarterly Depreciation Expense fell 61.18% year-over-year to $3744.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $31355.0 (down 18.39% YoY) and the FY2013 annual result came in at $37133.0, down 12.39% from the prior year.
  • Depreciation Expense eased to $3744.0 in Q3 2014 per IRD's latest filing, from $9630.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $10721.0 in Q1 2012 and bottomed at $3744.0 in Q3 2014.
  • The 4-year median for Depreciation Expense is $9886.0 (2011), against an average of $9491.4.
  • The widest annual swing landed in 2012, when Depreciation Expense grew 5.87%; it then tumbled 61.18% in 2014.
  • Tracing IRD's Depreciation Expense over 4 years: stood at $10166.0 in 2011, then advanced by 0.56% to $10223.0 in 2012, then fell by 12.58% to $8937.0 in 2013, then slumped by 58.11% to $3744.0 in 2014.
  • Per Business Quant, the three latest IRD Depreciation Expense figures stand at $3744.0 (Q3 2014), $9630.0 (Q2 2014), and $9044.0 (Q1 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Opus Genetics 357.99 Mn 298.03 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2014 3,744.00
Jun 30, 2014 9,630.00
Mar 31, 2014 9,044.00
Dec 31, 2013 8,937.00
Sep 30, 2013 9,645.00
Jun 30, 2013 9,235.00
Mar 31, 2013 9,316.00
Dec 31, 2012 10,223.00
Sep 30, 2012 10,721.00
Jun 30, 2012 10,721.00
Mar 31, 2012 10,721.00
Dec 31, 2011 10,166.00
Sep 30, 2011 10,127.00
Jun 30, 2011 10,650.00